C0003153479P
This role involves launching and promoting Asundexian, a next-generation stroke prevention therapy, within the Flushing, NY territory. The representative will drive clinical demand, navigate formulary access, and build strategic relationships with key healthcare stakeholders. The position focuses on institutional and specialty sales to accelerate the adoption of this innovative therapy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for C0003153479P.
23% above the average for this role
Institutional & Specialty Sales Consultant, Cardiology - Salt Lake City, UT
bayer
Institutional & Specialty Sales Consultant, Cardiology - Syracuse, NY
City of Duncan, Oklahoma
Institutional & Specialty Sales Consultant, Cardiology- El Paso, TX
City of Duncan, Oklahoma
Institutional & Spec Sales Consultant - Manhattan, NY
bayer
Institutional & Specialty Sales Consultant, Cardiology - Springfield / Alton, IL
City of Duncan, Oklahoma
Institutional & Specialty Sales Consultant, Cardiology - San Diego, CA
City of Duncan, Oklahoma